Results 171 to 180 of about 57,759 (194)

Management of glioblastoma: State of the art and future directions

Ca-A Cancer Journal for Clinicians, 2020
Aaron Tan, David M Ashley, Giselle Lopez
exaly  

Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance

Nature Biomedical Engineering, 2021
Yongheng Wang, Yuhang Jiang, Dengshuai Wei   +2 more
exaly  

Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)

Journal of Clinical Oncology, 2023
Pamela Kunz, Paul J Catalano, George A Fisher   +2 more
exaly  

Temozolomide

Reactions Weekly, 2023
openaire   +1 more source

Temozolomide

Reactions Weekly, 2016
openaire   +2 more sources

Temozolomide

Reactions Weekly, 2018
openaire   +2 more sources

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Lancet Oncology, The, 2009
Roger Stupp, Monika E Hegi, Peter Hau
exaly  

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

Lancet, The, 2017
Michael A Vogelbaum, Anna K Nowak, Walter Taal   +2 more
exaly  

Temozolomide

Reactions Weekly, 2007
openaire   +1 more source

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

Lancet Oncology, The, 2012
Wolfgang Wick, Michael Platten
exaly